Published in J Cardiovasc Magn Reson on January 31, 2015
Athletic Cardiac Adaptation in Males Is a Consequence of Elevated Myocyte Mass. Circ Cardiovasc Imaging (2016) 1.39
Review of Journal of Cardiovascular Magnetic Resonance 2015. J Cardiovasc Magn Reson (2016) 0.75
Clinical recommendations for cardiovascular magnetic resonance mapping of T1, T2, T2* and extracellular volume: A consensus statement by the Society for Cardiovascular Magnetic Resonance (SCMR) endorsed by the European Association for Cardiovascular Imaging (EACVI). J Cardiovasc Magn Reson (2017) 0.75
2013 ESC guidelines on the management of stable coronary artery disease: the Task Force on the management of stable coronary artery disease of the European Society of Cardiology. Eur Heart J (2013) 9.54
Cardiovascular magnetic resonance and single-photon emission computed tomography for diagnosis of coronary heart disease (CE-MARC): a prospective trial. Lancet (2011) 7.50
Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med (2004) 6.27
T1 mapping for myocardial extracellular volume measurement by CMR: bolus only versus primed infusion technique. JACC Cardiovasc Imaging (2013) 4.21
Diagnosis and management of the cardiac amyloidoses. Circulation (2005) 3.96
Effects of adenosine on human coronary arterial circulation. Circulation (1990) 3.86
Extracellular volume imaging by magnetic resonance imaging provides insights into overt and sub-clinical myocardial pathology. Eur Heart J (2012) 3.78
Myocardial T1 mapping and extracellular volume quantification: a Society for Cardiovascular Magnetic Resonance (SCMR) and CMR Working Group of the European Society of Cardiology consensus statement. J Cardiovasc Magn Reson (2013) 3.52
Myocardial extravascular extracellular volume fraction measurement by gadolinium cardiovascular magnetic resonance in humans: slow infusion versus bolus. J Cardiovasc Magn Reson (2011) 2.96
T1-mapping in the heart: accuracy and precision. J Cardiovasc Magn Reson (2014) 2.48
Extracellular volume fraction mapping in the myocardium, part 2: initial clinical experience. J Cardiovasc Magn Reson (2012) 2.09
Comparison of T1 mapping techniques for ECV quantification. Histological validation and reproducibility of ShMOLLI versus multibreath-hold T1 quantification equilibrium contrast CMR. J Cardiovasc Magn Reson (2012) 1.67
Myocardial extracellular volume fraction from T1 measurements in healthy volunteers and mice: relationship to aging and cardiac dimensions. JACC Cardiovasc Imaging (2013) 1.65
Extracellular matrix remodeling in heart failure: a role for de novo angiotensin II generation. Circulation (1997) 1.62
Cardiovascular magnetic resonance measurement of myocardial extracellular volume in health and disease. Heart (2012) 1.56
The relationship between myocardial extracellular matrix remodeling and ventricular function. Eur J Cardiothorac Surg (2006) 1.54
Assessment of regional left ventricular function: accuracy and reproducibility of positioning standard short-axis sections in cardiac MR imaging. Radiology (2005) 1.40
Myocardial late gadolinium enhancement in specific cardiomyopathies by cardiovascular magnetic resonance: a preliminary experience. J Cardiovasc Med (Hagerstown) (2007) 1.26
Human myocardial histologic characteristics in congestive heart failure. Circulation (1983) 1.23
Use of cardiovascular magnetic resonance imaging in acute coronary syndromes. Circulation (2009) 1.08
Standardization of T1 measurements with MOLLI in differentiation between health and disease--the ConSept study. J Cardiovasc Magn Reson (2013) 1.07
Differential myocardial abundance of collagen type I and type III mRNA in dilated cardiomyopathy: effects of myocardial inflammation. Cardiovasc Res (1998) 0.88
Modified Look-Locker inversion recovery (MOLLI) for high-resolution T1 mapping of the heart. Magn Reson Med (2004) 6.27
Assessment of non-ST-segment elevation acute coronary syndromes with cardiac magnetic resonance imaging. J Am Coll Cardiol (2004) 2.88
Human myocardium: single-breath-hold MR T1 mapping with high spatial resolution--reproducibility study. Radiology (2006) 2.84
MR imaging of cardiac tumors and masses: a review of methods and clinical applications. Radiology (2013) 2.01
Reperfusion haemorrhage as determined by cardiovascular MRI is a predictor of adverse left ventricular remodelling and markers of late arrhythmic risk. Heart (2010) 1.89
Relationship between central sympathetic drive and magnetic resonance imaging-determined left ventricular mass in essential hypertension. Circulation (2007) 1.69
Aortic regurgitation quantification using cardiovascular magnetic resonance: association with clinical outcome. Circulation (2012) 1.58
Coronary artery disease: myocardial perfusion MR imaging with sensitivity encoding versus conventional angiography. Radiology (2005) 1.48
Gender differences in sympathetic neural activation following uncomplicated acute myocardial infarction. Eur Heart J (2009) 1.48
Characterization of acute myocardial infarction by magnetic resonance imaging. JACC Cardiovasc Imaging (2009) 1.42
Sympathetic activation and vasoregulation in response to carbohydrate ingestion in patients with congestive heart failure. Can J Cardiol (2012) 1.39
Differential polarization of alveolar macrophages and bone marrow-derived monocytes following chemically and pathogen-induced chronic lung inflammation. J Leukoc Biol (2010) 1.35
Complete Versus culprit-Lesion only PRimary PCI Trial (CVLPRIT): a multicentre trial testing management strategies when multivessel disease is detected at the time of primary PCI: rationale and design. EuroIntervention (2013) 1.28
Reference values for healthy human myocardium using a T1 mapping methodology: results from the International T1 Multicenter cardiovascular magnetic resonance study. J Cardiovasc Magn Reson (2014) 1.27
Timing of cardiovascular MR imaging after acute myocardial infarction: effect on estimates of infarct characteristics and prediction of late ventricular remodeling. Radiology (2011) 1.18
Appearance of microvascular obstruction on high resolution first-pass perfusion, early and late gadolinium enhancement CMR in patients with acute myocardial infarction. J Cardiovasc Magn Reson (2009) 1.16
High spatial resolution myocardial perfusion cardiac magnetic resonance for the detection of coronary artery disease. Eur Heart J (2008) 1.14
Reproducibility of first-pass cardiovascular magnetic resonance myocardial perfusion. J Magn Reson Imaging (2013) 1.11
Cost-effectiveness of cardiovascular magnetic resonance in the diagnosis of coronary heart disease: an economic evaluation using data from the CE-MARC study. Heart (2013) 1.08
Caseous calcification of the mitral valve complicated by embolization, mitral regurgitation, and pericardial constriction. Eur Heart J Cardiovasc Imaging (2012) 1.08
k-Space and time sensitivity encoding-accelerated myocardial perfusion MR imaging at 3.0 T: comparison with 1.5 T. Radiology (2008) 1.07
XCL1 (lymphotactin) chemokine produced by activated CD8 T cells during the chronic stage of infection with Mycobacterium tuberculosis negatively affects production of IFN-gamma by CD4 T cells and participates in granuloma stability. J Leukoc Biol (2007) 1.05
The effect of microvascular obstruction and intramyocardial hemorrhage on contractile recovery in reperfused myocardial infarction: insights from cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2013) 1.03
Estimates of systolic and diastolic myocardial blood flow by dynamic contrast-enhanced MRI. Magn Reson Med (2010) 1.00
Troponin-I concentration 72 h after myocardial infarction correlates with infarct size and presence of microvascular obstruction. Heart (2007) 0.98
Systolic versus diastolic acquisition in myocardial perfusion MR imaging. Radiology (2012) 0.97
Isolated left ventricular apical hypoplasia evaluated by cardiovascular magnetic resonance and gadolinium enhancement techniques. J Am Coll Cardiol (2011) 0.97
Visualization of coronary venous anatomy by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2009) 0.96
Reproducibility of myocardial strain and left ventricular twist measured using complementary spatial modulation of magnetization. J Magn Reson Imaging (2013) 0.95
Local pulmonary immunotherapy with siRNA targeting TGFβ1 enhances antimicrobial capacity in Mycobacterium tuberculosis infected mice. Tuberculosis (Edinb) (2010) 0.93
Intrapulmonary delivery of XCL1-targeting small interfering RNA in mice chronically infected with Mycobacterium tuberculosis. Am J Respir Cell Mol Biol (2008) 0.92
Construction and validation of anisotropic and orthotropic ventricular geometries for quantitative predictive cardiac electrophysiology. Interface Focus (2010) 0.91
The Coumadin Ridge: An Important Example of a Left Atrial Pseudotumour demonstrated by Cardiovascular Magnetic Resonance Imaging. J Radiol Case Rep (2009) 0.91
Relationship between myocardial edema and regional myocardial function after reperfused acute myocardial infarction: an MR imaging study. Radiology (2013) 0.90
High-resolution versus standard-resolution cardiovascular MR myocardial perfusion imaging for the detection of coronary artery disease. Circ Cardiovasc Imaging (2012) 0.90
Relationship of dysglycemia to acute myocardial infarct size and cardiovascular outcome as determined by cardiovascular magnetic resonance. J Cardiovasc Magn Reson (2010) 0.89
Non-invasive diagnosis of early pulmonary disease in PECAM-deficient mice using infrared pulse oximetry. Exp Mol Pathol (2009) 0.88
Carbohydrate ingestion, with transient endogenous insulinaemia, produces both sympathetic activation and vasodilatation in normal humans. Clin Sci (Lond) (2002) 0.88
Myocardial blood flow at rest and stress measured with dynamic contrast-enhanced MRI: comparison of a distributed parameter model with a Fermi function model. Magn Reson Med (2013) 0.88
3D Echo systematically underestimates right ventricular volumes compared to cardiovascular magnetic resonance in adult congenital heart disease patients with moderate or severe RV dilatation. J Cardiovasc Magn Reson (2011) 0.88
Comparison of the Diagnostic Performance of Four Quantitative Myocardial Perfusion Estimation Methods Used in Cardiac MR Imaging: CE-MARC Substudy. Radiology (2014) 0.87
Improving highly accelerated fat fraction measurements for clinical trials in muscular dystrophy: origin and quantitative effect of R2* changes. Radiology (2015) 0.86
CT triple rule-out examination: higher radiation dose without clinical benefit. BMJ (2013) 0.86
Effect of improving spatial or temporal resolution on image quality and quantitative perfusion assessment with k-t SENSE acceleration in first-pass CMR myocardial perfusion imaging. Magn Reson Med (2010) 0.85
Sympathetic nerve hyperactivity and its effect in postmenopausal women. J Hypertens (2011) 0.85
Arterial pressure lowering effect of chronic atenolol therapy in hypertension and vasoconstrictor sympathetic drive. Hypertension (2004) 0.85
Association of diabetes with increased all-cause mortality following primary percutaneous coronary intervention for ST-segment elevation myocardial infarction in the contemporary era. Diab Vasc Dis Res (2011) 0.85
Direct ambulance admission to the cardiac catheterization laboratory significantly reduces door-to-balloon times in primary percutaneous coronary intervention. Am Heart J (2008) 0.85
Real-world outcome from ST elevation myocardial infarction in the very elderly before and after the introduction of a 24/7 primary percutaneous coronary intervention service. Am Heart J (2010) 0.85
Quantitative three-dimensional cardiovascular magnetic resonance myocardial perfusion imaging in systole and diastole. J Cardiovasc Magn Reson (2014) 0.85
Measurement of left ventricular dimensions with contrast-enhanced three-dimensional cine imaging facilitated by k-t SENSE. J Cardiovasc Magn Reson (2008) 0.84
Serial change in health-related quality of life over 1 year after transcatheter aortic valve implantation: predictors of health outcomes. J Am Coll Cardiol (2012) 0.84
Cardiovascular magnetic resonance of scar and ischemia burden early after acute ST elevation and non-ST elevation myocardial infarction. J Cardiovasc Magn Reson (2008) 0.84
Endocardial and epicardial myocardial perfusion determined by semi-quantitative and quantitative myocardial perfusion magnetic resonance. Int J Cardiovasc Imaging (2011) 0.83
Investigating the quantitative fidelity of prospectively undersampled chemical shift imaging in muscular dystrophy with compressed sensing and parallel imaging reconstruction. Magn Reson Med (2013) 0.82
Evaluation of a comprehensive cardiovascular magnetic resonance protocol in young adults late after the arterial switch operation for d-transposition of the great arteries. J Cardiovasc Magn Reson (2014) 0.81
Diagnostic value of CMR in patients with biomarker-positive acute chest pain and unobstructed coronary arteries. JACC Cardiovasc Imaging (2010) 0.80
Prognostic Value of Cardiovascular Magnetic Resonance and Single-Photon Emission Computed Tomography in Suspected Coronary Heart Disease: Long-Term Follow-up of a Prospective, Diagnostic Accuracy Cohort Study. Ann Intern Med (2016) 0.80
Virtual tissue engineering of the human atrium: modelling pharmacological actions on atrial arrhythmogenesis. Eur J Pharm Sci (2011) 0.79
Hypertensive left ventricular hypertrophy: a mechanistic approach to optimizing regression assessed by cardiovascular magnetic resonance. J Hypertens (2012) 0.79
Aortic remodelling following the treatment and regression of hypertensive left ventricular hypertrophy: a cardiovascular magnetic resonance study. Clin Exp Hypertens (2014) 0.79
Cardiac MR imaging to measure myocardial blood flow response to the cold pressor test in healthy smokers and nonsmokers. Radiology (2013) 0.79
Advanced cardiovascular magnetic resonance myocardial perfusion imaging: high-spatial resolution versus 3-dimensional whole-heart coverage. Circ Cardiovasc Imaging (2013) 0.79
Assessing Myocardial Extracellular Volume by T1 Mapping to Distinguish Hypertrophic Cardiomyopathy From Athlete's Heart. J Am Coll Cardiol (2016) 0.78
Relationship of cardiac biomarkers and reversible and irreversible myocardial injury following acute myocardial infarction as determined by cardiovascular magnetic resonance. Int J Cardiol (2011) 0.78
Robust myocardial T2 and T2 * mapping at 3T using image-based shimming. J Magn Reson Imaging (2014) 0.78
Sympathetic nerve hyperactivity is associated with increased peripheral vascular resistance in hypopituitary patients with growth hormone deficiency. Clin Endocrinol (Oxf) (2002) 0.78
Reply: Complete Revascularization in Patients Undergoing Primary Percutaneous Coronary Intervention for STEMI: Is It Really What We Should Be Doing? J Am Coll Cardiol (2015) 0.78
Quantification of myocardial blood flow with cardiovascular magnetic resonance throughout the cardiac cycle. J Cardiovasc Magn Reson (2015) 0.78
Contribution of noninvasive imaging to the diagnosis and follow-up of Takotsubo cardiomyopathy. JACC Cardiovasc Imaging (2009) 0.78
Understanding LV remodeling following myocardial infarction: are T1 maps by CMR the new guide? JACC Cardiovasc Imaging (2012) 0.77
Glycoprotein IIb/IIIa inhibitor associated severe thrombocytopenia in patients with coronary artery disease: Clinical course and outcomes. Platelets (2011) 0.77
Accelerated, high spatial resolution cardiovascular magnetic resonance myocardial perfusion imaging. J Nucl Cardiol (2011) 0.77
The distribution and prognosis of anomalous coronary arteries identified by cardiovascular magnetic resonance: 15 year experience from two tertiary centres. J Cardiovasc Magn Reson (2014) 0.77
Three-year clinical outcome with the Endeavor™ zotarolimus-eluting stent in primary percutaneous coronary intervention for ST elevation myocardial infarction: the Endeavor™ primary PCI study (E-PPCI). J Interv Cardiol (2011) 0.76
Resting sympathetic nerve activity is related to age, sex and arterial pressure but not to α2-adrenergic receptor subtype. J Hypertens (2010) 0.76
Individual component analysis of the multi-parametric cardiovascular magnetic resonance protocol in the CE-MARC trial. J Cardiovasc Magn Reson (2015) 0.76
Safety and feasibility of dobutamine stress cardiac magnetic resonance for cardiovascular assessment prior to renal transplantation. J Cardiovasc Med (Hagerstown) (2014) 0.76